Literature DB >> 27491302

Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer.

Francesca Rappa1,2, Alessandro Pitruzzella3,4, Antonella Marino Gammazza3,4, Rosario Barone3,4, Emanuele Mocciaro3, Giovanni Tomasello3,4, Francesco Carini3, Felicia Farina3, Giovanni Zummo3, Everly Conway de Macario4,5,6, Alberto Jl Macario4,5,6, Francesco Cappello3,4.   

Abstract

Large bowel carcinogenesis involves accumulation of genetic alterations leading to transformation of normal mucosa into dysplasia and, lastly, adenocarcinoma. It is pertinent to elucidate the molecular changes occurring in the pre-neoplastic lesions to facilitate early diagnosis and treatment. Heat shock proteins (Hsps), many of which are molecular chaperones, are implicated in carcinogenesis, and their variations with tumor progression encourage their study as biomarkers. There are many reports on Hsps and cancer but none to our knowledge on their systematic quantification in pre-neoplastic lesions of the large bowel. We performed immunohistochemical determinations of Hsp10, Hsp60, Hsp70, and Hsp90 in biopsies of large bowel tubular adenomas with moderate grade of dysplasia and compared to normal mucosa and adenocarcinoma with a moderate grade of differentiation (G2). A significant elevation of Hsp10 and Hsp60 only, i.e., in the absence of elevation of Hsp70 or Hsp90, in both epithelium and lamina propria was found in tubular adenoma by comparison with normal mucosa. In contrast, adenocarcinoma was characterized by the highest levels of Hsp10 and Hsp60 in epithelium and lamina propria, accompanied by the highest levels of Hsp70 only in epithelium and of Hsp90 only in lamina propria, by comparison with normal and tubular adenoma counterparts. Hsp10 and Hsp60 are promising biomarkers for early diagnosis of tubular adenoma and for its differentiation from more advanced malignant lesions. Hsp10 and Hsp60 may be implicated in carcinogenesis from its very early steps and, thus, are potentially convenient targets for therapy.

Entities:  

Keywords:  Biomarker; Chaperone; Dysplasia; Hsps; Large bowel; Tubular adenoma

Mesh:

Substances:

Year:  2016        PMID: 27491302      PMCID: PMC5003810          DOI: 10.1007/s12192-016-0721-5

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  38 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis.

Authors:  Francesco Cappello; Antonino Di Stefano; Silvestro E D'Anna; Claudio F Donner; Giovanni Zummo
Journal:  Lancet Oncol       Date:  2005-10       Impact factor: 41.316

3.  HSP60 expression during carcinogenesis: a molecular "proteus" of carcinogenesis?

Authors:  Francesco Cappello; Giovanni Zummo
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

4.  HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway.

Authors:  Sanjiv Gupta; A A Knowlton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-02-16       Impact factor: 4.733

5.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease.

Authors:  Francesco Cappello; Antonino Di Stefano; Sabrina David; Francesco Rappa; Rita Anzalone; Giampiero La Rocca; Silvestro E D'Anna; Francesca Magno; Claudio F Donner; Bruno Balbi; Giovanni Zummo
Journal:  Cancer       Date:  2006-11-15       Impact factor: 6.860

Review 7.  Inflammation and immune surveillance in cancer.

Authors:  Melvyn T Chow; Andreas Möller; Mark J Smyth
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

Review 8.  The role of heat shock proteins in mammalian differentiation and development.

Authors:  D Walsh; J Grantham; X O Zhu; J Wei Lin; M van Oosterum; R Taylor; M Edwards
Journal:  Environ Med       Date:  1999-12

9.  Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery.

Authors:  Claudia Campanella; Francesca Rappa; Carmelo Sciumè; Antonella Marino Gammazza; Rosario Barone; Fabio Bucchieri; Sabrina David; Giuseppe Curcurù; Celeste Caruso Bavisotto; Alessandro Pitruzzella; Girolamo Geraci; Giuseppe Modica; Felicia Farina; Giovanni Zummo; Stefano Fais; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Cancer       Date:  2015-06-08       Impact factor: 6.860

10.  Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy.

Authors:  L M Vargas-Roig; F E Gago; O Tello; J C Aznar; D R Ciocca
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

View more
  14 in total

Review 1.  The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer.

Authors:  Joseph R Inigo; Dhyan Chandra
Journal:  J Hematol Oncol       Date:  2022-07-21       Impact factor: 23.168

2.  Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer.

Authors:  Anne-Marie Ray; Nilshad Salim; Mckayla Stevens; Siddhi Chitre; Sanofar Abdeen; Alex Washburn; Jared Sivinski; Heather M O'Hagan; Eli Chapman; Steven M Johnson
Journal:  Bioorg Med Chem       Date:  2021-04-19       Impact factor: 3.461

3.  Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis.

Authors:  T C Kenny; P Hart; M Ragazzi; M Sersinghe; J Chipuk; M A K Sagar; K W Eliceiri; T LaFramboise; S Grandhi; J Santos; A K Riar; L Papa; M D'Aurello; G Manfredi; M G Bonini; D Germain
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

4.  Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics.

Authors:  Xinlu Liu; Yejing Weng; Peng Liu; Zhigang Sui; Lei Zhou; Yinpeng Huang; Lihua Zhang; Yukui Zhang; Xiaodong Tan
Journal:  Onco Targets Ther       Date:  2018-06-06       Impact factor: 4.147

5.  Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in Clinics.

Authors:  Celeste Caruso Bavisotto; Calogero Cipolla; Giuseppa Graceffa; Rosario Barone; Fabio Bucchieri; Donatella Bulone; Daniela Cabibi; Claudia Campanella; Antonella Marino Gammazza; Alessandro Pitruzzella; Rossana Porcasi; Pier Luigi San Biagio; Giovanni Tomasello; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello; Francesca Rappa
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

6.  Increased expression of heat shock protein (HSP) 10 and HSP70 correlates with poor prognosis of nasopharyngeal carcinoma.

Authors:  Juan Feng; Yuting Zhan; Yuting Zhang; Hongmei Zheng; Weiyuan Wang; Songqing Fan
Journal:  Cancer Manag Res       Date:  2019-09-06       Impact factor: 3.989

7.  Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.

Authors:  Weibing Fan; Shuang-Shi Fan; Juan Feng; Desheng Xiao; Songqing Fan; Jiadi Luo
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

8.  Oncogenic Potential of Bisphenol A and Common Environmental Contaminants in Human Mammary Epithelial Cells.

Authors:  Vidhya A Nair; Satu Valo; Päivi Peltomäki; Khuloud Bajbouj; Wael M Abdel-Rahman
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

Review 9.  The Functions and Therapeutic Potential of Heat Shock Proteins in Inflammatory Bowel Disease-An Update.

Authors:  Abdullah Hoter; Hassan Y Naim
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

10.  Hsp60 and IL-8 axis promotes apoptosis resistance in cancer.

Authors:  Sandeep Kumar; Jordan O'Malley; Ajay Kumar Chaudhary; Joseph R Inigo; Neelu Yadav; Rahul Kumar; Dhyan Chandra
Journal:  Br J Cancer       Date:  2019-11-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.